Amicrobe Inc.: Amicrobe Selects Clinical Formulation for Ami

Amicrobe Inc.: Amicrobe Selects Clinical Formulation for Amicidin-a PFC, Supported by Department of Defense for Prolonged Field Care of Injured Warfighters

Backed by a $3.99M Department of Defense award, issued August 2021 through MTEC, Amicidin-a PFC is intended to prevent life-threatening infections in military field settings CARLSBAD, Calif.

Related Keywords

California , United States , Kostenloser Wertpapierhandel , Daniel Huang , Michael Bevilacqua , Pm Department Of Defense , Us Army Medical Research , Prnewswire Amicrobe Inc , M Us Department Of Defense , Infectious Diseases Research Program , Development Command Military Infectious Diseases Research Program , Technology Enterprise Consortium , Development Command , Prolonged Field Care , Amicidina Surgical Gel , Medical Research , Military Infectious Diseases Research Program , Medical Technology Enterprise Consortium , Amicrobe , Elects , Linical , Formulation , Micidin , Upported , Department , Defense , Bprolonged , Field , Mare , Injured , Warfighters ,